Boston Scientific to Pay Johnson & Johnson $1.73B Settlement

Grab this video:

By copying code you agree to Grab Network's Membership Agreement.
Grab Networks

Johnson & Johnson (JNJ) and Boston Scientific (BSX) said today that they have agreed on a settlement in three stent-related patent disputes. Boston Scientific will pay a total of $1.73 billion to settle suits in which Johnson & Johnson alleged patent infringement on various stent products.

Credit: Market News Video
Copyright: Market News Video

Published by Grab Networks

A resource for website publishers who want to embed quality, licensed content on a wide variety of topics.  View profile

To comment, please sign in to your Yahoo! account, or sign up for a new account.